DA32 Life Science Tech Acquisition Corp. reported earnings results for the eight months ended December 31, 2021. For the eight months, the company reported net loss was USD 0.571294 million.
DA32 Life Science Tech Acquisition Corp.
Equities
DALS
US23312M1062
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+79.86% | 4.85B | |
+1.60% | 1.01B | |
+2.00% | 981M | |
+41.91% | 872M | |
+30.78% | 851M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+23.44% | 542M |